Analyses of The Cancer Genome Atlas (TCGA) and Chinese Glioma Genome Atlas (CGGA) databases revealed that GBM patient prognosis was negatively correlated with LDHA expression (Figure 8A-B). The gene discussed is LDHA; the disease is central nervous system cancer.